Mp16-01 Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Carcinoma in Situ (cis), Bcg-unresponsive Non-muscle Invasive Bladder Cancer (nmibc): Longer-term Follow-up From the Phase Iii Trial